meropenem + noradrenaline

Meropenem + noradrenaline is a combination of two drugs commonly co-administered in critical care settings, particularly for patients with severe infections and septic shock. Meropenem is a broad-spectrum carbapenem antibiotic that acts by inhibiting bacterial cell wall synthesis, leading to cell death. It is effective against a wide range of Gram-positive and Gram-negative bacteria[1][8]. Noradrenaline (also known as norepinephrine) is a sympathomimetic vasopressor used to manage hypotension, especially in septic shock, by stimulating alpha-adrenergic receptors to induce vasoconstriction and increase blood pressure[5]. This combination does not represent a fixed-dose pharmaceutical product but rather the concurrent use of both agents via intravenous infusion in intensive care units. Compatibility studies indicate that these drugs can be administered together via Y-site infusion under certain concentration limits without significant risk of physical incompatibility[2][7].

Other names

meropenem + norepinephrinemeropenem and noradrenalinemeropenem and norepinephrine